Short-term Efficacy of Micropulse Yellow Laser in Non-center-involving Diabetic Macular Edema: Preliminary Results

about

Short-term Efficacy of Micropulse Yellow Laser in Non-center-involving Diabetic Macular Edema: Preliminary Results

Item

http://www.wikidata.org/entity/Q58602990

description

scientific article published on 31 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@en

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@nl

type

Item

label

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@en

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@nl

prefLabel

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@en

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@nl

P1476

Short-term Efficacy of Micropu ...... lar Edema: Preliminary Results

@en

P2093

Emin Özmert

http://www.w3.org/2001/XMLSchema#string

Figen Batıoğlu

http://www.w3.org/2001/XMLSchema#string

Sibel Demirel

http://www.w3.org/2001/XMLSchema#string

P2860

Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics

The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser.

Subretinal fibrosis after laser photocoagulation for diabetic macular edema.

Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.

Long-term safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema.

Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

P304

245-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4274/TJO.04657

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mehmet Fatih Kağan Değirmenci

Sibel Demirel

Figen Şermet

Emin Özmert

P577

2018-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30405946

http://www.w3.org/2001/XMLSchema#string

P932

6216533

http://www.w3.org/2001/XMLSchema#string